MarketPeel
Insider Trading Intelligence
AK

Arthur J. Klausner

MNPR
DIRECTOR · MONOPAR THERAPEUTICS · CIK 0001207790
FILING MIX · LIFETIME60%/40%
BUYS
27
SELLS
18
TOTAL VALUE
$343.9K
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
8,762
AVG SELL PX
$67.15
TRADE KIND
SHOWING 45 / 45
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 4 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Arthur J. Klausner, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+0.00%+7.26%+2.06%+5.20%+5.20%
14d2+100.00%-1.05%+0.81%-1.85%-1.85%
30d2+0.00%+6.08%+2.25%+3.83%+3.83%
60d2+100.00%-17.84%+0.94%-18.79%-18.79%
90d2+100.00%-11.65%-2.22%-9.43%-9.43%
180d2+100.00%-10.14%+11.58%-21.73%-21.73%
1y2(2 pending)
2y2(2 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
MNPR · 8,762 shares · as of Dec 18, 2025
07,71615,43223,14730,86320212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 27 buys / 18 sellsCOVERAGE · 24 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
MNPR
MONOPAR THERAPEUTICS
SALE
4,660$67.06$312.5K9,223Dec 18, 2025Dec 19, 2025View →
MNPR
MONOPAR THERAPEUTICS
SALE
461$68.09$31.4K8,762Dec 18, 2025Dec 19, 2025View →
MNPR
MONOPAR THERAPEUTICS
PURCHASE
7,71013,883Dec 16, 2025Dec 17, 2025View →
MNPR
MONOPAR THERAPEUTICS
PURCHASEGRANT
Stock grant
2,9242,924Dec 2, 2025Dec 8, 2025View →
MNPR
MONOPAR THERAPEUTICS
PURCHASEGRANT
Stock grant
11,36511,365Mar 4, 2025Mar 7, 2025View →
MNPR
MONOPAR THERAPEUTICS
SALE
2,5330Dec 31, 2023Jan 3, 2024View →
MNPR
MONOPAR THERAPEUTICS
PURCHASE
2,53330,863Dec 31, 2023Jan 3, 2024View →
MNPR
MONOPAR THERAPEUTICS
SALE
2,5332,533Sep 30, 2023Oct 3, 2023View →
MNPR
MONOPAR THERAPEUTICS
PURCHASE
2,53328,330Sep 30, 2023Oct 3, 2023View →
MNPR
MONOPAR THERAPEUTICS
SALE
2,5345,066Jun 30, 2023Jul 3, 2023View →
MNPR
MONOPAR THERAPEUTICS
PURCHASE
2,53425,797Jun 30, 2023Jul 3, 2023View →
MNPR
MONOPAR THERAPEUTICS
SALE
2,5337,600Mar 31, 2023Apr 4, 2023View →
MNPR
MONOPAR THERAPEUTICS
PURCHASE
2,53323,263Mar 31, 2023Apr 4, 2023View →
MNPR
MONOPAR THERAPEUTICS
PURCHASEGRANT
Stock grant
13,93013,930Feb 1, 2023Feb 3, 2023View →
MNPR
MONOPAR THERAPEUTICS
PURCHASEGRANT
Stock grant
10,13310,133Feb 1, 2023Feb 3, 2023View →
MNPR
MONOPAR THERAPEUTICS
SALE
2,8590Dec 31, 2022Jan 3, 2023View →
MNPR
MONOPAR THERAPEUTICS
PURCHASE
2,85920,730Dec 31, 2022Jan 3, 2023View →
MNPR
MONOPAR THERAPEUTICS
SALE
2,8592,859Sep 30, 2022Oct 3, 2022View →
MNPR
MONOPAR THERAPEUTICS
PURCHASE
2,85917,871Sep 30, 2022Oct 3, 2022View →
MNPR
MONOPAR THERAPEUTICS
PURCHASE
2,85915,012Jun 30, 2022Jul 1, 2022View →
MNPR
MONOPAR THERAPEUTICS
SALE
2,8595,718Jun 30, 2022Jul 1, 2022View →
MNPR
MONOPAR THERAPEUTICS
SALE
2,8598,577Mar 31, 2022Apr 1, 2022View →
MNPR
MONOPAR THERAPEUTICS
PURCHASE
2,85912,153Mar 31, 2022Apr 1, 2022View →
MNPR
MONOPAR THERAPEUTICS
PURCHASEGRANT
Stock grant
15,12815,128Feb 2, 2022Feb 4, 2022View →
MNPR
MONOPAR THERAPEUTICS
PURCHASEGRANT
Stock grant
11,43611,436Feb 2, 2022Feb 4, 2022View →
MNPR
MONOPAR THERAPEUTICS
SALE
7510Dec 31, 2021Jan 4, 2022View →
MNPR
MONOPAR THERAPEUTICS
PURCHASE
7519,294Dec 31, 2021Jan 4, 2022View →
MNPR
MONOPAR THERAPEUTICS
SALE
751751Sep 30, 2021Oct 1, 2021View →
MNPR
MONOPAR THERAPEUTICS
PURCHASE
7518,543Sep 30, 2021Oct 1, 2021View →
MNPR
MONOPAR THERAPEUTICS
PURCHASE
7527,792Jun 30, 2021Jul 2, 2021View →
MNPR
MONOPAR THERAPEUTICS
SALE
7521,502Jun 30, 2021Jul 2, 2021View →
MNPR
MONOPAR THERAPEUTICS
PURCHASE
7517,040Mar 31, 2021Apr 1, 2021View →
MNPR
MONOPAR THERAPEUTICS
SALE
7512,254Mar 31, 2021Apr 1, 2021View →
MNPR
MONOPAR THERAPEUTICS
PURCHASEGRANT
Stock grant
3,0053,005Jan 26, 2021Jan 28, 2021View →
MNPR
MONOPAR THERAPEUTICS
PURCHASEGRANT
Stock grant
4,4434,443Jan 26, 2021Jan 28, 2021View →
MNPR
MONOPAR THERAPEUTICS
SALE
3220Dec 31, 2020Jan 5, 2021View →
MNPR
MONOPAR THERAPEUTICS
PURCHASE
3226,289Dec 31, 2020Jan 5, 2021View →
MNPR
MONOPAR THERAPEUTICS
SALE
322322Sep 30, 2020Jan 5, 2021View →
MNPR
MONOPAR THERAPEUTICS
PURCHASE
3225,967Sep 30, 2020Jan 5, 2021View →
MNPR
MONOPAR THERAPEUTICS
SALE
323644Jun 30, 2020Jul 2, 2020View →
MNPR
MONOPAR THERAPEUTICS
PURCHASE
3235,645Jun 30, 2020Jul 2, 2020View →
MNPR
MONOPAR THERAPEUTICS
PURCHASE
3225,322Mar 31, 2020Apr 1, 2020View →
MNPR
MONOPAR THERAPEUTICS
SALE
322967Mar 31, 2020Apr 1, 2020View →
MNPR
MONOPAR THERAPEUTICS
PURCHASEGRANT
Stock grant
1,2891,289Jan 31, 2020Feb 20, 2020View →
MNPR
MONOPAR THERAPEUTICS
PURCHASEGRANT
Stock grant
5,6465,646Jan 31, 2020Feb 20, 2020View →
Other insiders · MNPR
Loading peer insiders…
About this filer
CIK 0001207790
ROLE
Director
PRIMARY
MNPR
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001207790DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback